Berallo, Jarad Sean Q.

HRN: 27-96-10  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2025
CO-AMOXICLAV 625MG (TAB)
10/16/2025
10/23/2025
PO
625 MG/TAB
Q8H
MULTIPLE LACERATIONS OF THE FACE
Remove - Pending Acceptance
10/16/2025
MUPIROCIN 2%, 15G (TUBE)
10/16/2025
10/23/2025
TOPICAL
2%
BID
MULTIPLE ABRASIONS
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: